Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 248 | 53 | 185 |
| Samples | 237 | 53 | 176 |
| Peptides | 171 | 27 | 142 |
Function
NKAP · NFKB activating protein
This gene encodes a protein that is involved in the activation of the ubiquitous transcription factor NF-kappaB. This protein is associated with the the histone deacetylase HDAC3 and with the Notch corepressor complex, and it thereby acts as a transcriptional repressor of Notch target genes. It is also required for alphabeta T cell development. A related pseudogene has been identified on chromosome X, while a related and intronless retrocopy, which has an intact CDS and may be functional, is located on chromosome 6. [provided by RefSeq, May 2010].
Isoforms & Proteins
1 transcript · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
| Transcript | UniProt | Mutations | Peptides |
|---|---|---|---|
| ENST00000371410 | Q8N5F7 | 248 | 171 |
Gene Properties
Recurrent Mutations
All 171 amino-acid changes on canonical ENST00000371410 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in NKAP · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in NKAP – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| T-Lymphoblastic Leukemia | 2/40 5% | 0/0 0% |
| T-Cell Non-Hodgkins Lymphoma | 1/26 4% | 0/0 0% |
| Endometrial Carcinoma | 2/42 5% | 20/612 3% |
| Germ Cell Tumour | 2/25 8% | 1/169 1% |
| Plasma Cell Myeloma | 0/44 0% | 4/305 1% |
| Chondrosarcoma | 1/14 7% | 0/75 0% |
| Non-Small Cell Lung Carcinoma | 8/304 3% | 9/1390 1% |
| Ovarian Carcinoma | 6/109 6% | 5/998 0% |
| Colorectal Carcinoma | 7/143 5% | 23/3239 1% |
| Gastric Carcinoma | 0/74 0% | 15/1809 1% |
| Cervical Carcinoma | 0/35 0% | 3/422 1% |
| Bladder Carcinoma | 0/58 0% | 6/956 1% |
| Squamous Cell Lung Carcinoma | 0/57 0% | 5/810 1% |
| Melanoma | 0/210 0% | 12/1899 1% |
| Breast Carcinoma | 3/144 2% | 16/3264 0% |
| Thyroid Gland Carcinoma | 3/45 7% | 5/1592 0% |
| Pancreatic Carcinoma | 3/89 3% | 5/1611 0% |
| B-Cell Non-Hodgkins Lymphoma | 3/88 3% | 9/2534 0% |
| Burkitts Lymphoma | 1/32 3% | 0/196 0% |
| Head and Neck Carcinoma | 2/85 2% | 5/1574 0% |
| Neuroendocrine Tumour | 1/154 1% | 2/577 0% |
| Biliary Tract Carcinoma | 0/54 0% | 4/950 0% |
| Other Sarcomas | 3/69 4% | 0/699 0% |
| Esophageal Squamous Cell Carcinoma | 0/51 0% | 10/2550 0% |
| Other Solid Cancers | 2/94 2% | 4/1515 0% |
| Kidney Carcinoma | 1/85 1% | 5/1862 0% |
| Hepatocellular Carcinoma | 0/46 0% | 6/2210 0% |
| Glioma | 1/52 2% | 4/2127 0% |
| Non-Cancerous | 1/104 1% | 1/830 0% |
| Other Blood Cancers | 0/61 0% | 3/2725 0% |
Mutation Distribution
Where NKAP is mutated · all tissues, split by cell line vs tissue
How many mutations in NKAP were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
GTEx Expression
Median TPM across 54 healthy tissues
Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.
Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.
Scroll or drag the mini-axis below the chart to browse all tissues.
Mutations
All 248 mutations in NKAP
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|